Published online before print February 2, 2006, doi: 10.1161/01.RES.0000207384.81818.d4
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 American Heart Association, Inc.
Integrative Physiology |
An In Vivo Analysis of Hematopoietic Stem Cell Potential
Hematopoietic Origin of Cardiac Valve Interstitial Cells
From the Department of Cell Biology and Anatomy (R.P.V., P.A.F., T.C.M., R.R.M., C.J.D.), Department of Medicine (Y.E., A.C.L., M.M., H.M., M.O.), and the Cardiovascular Developmental Biology Center (R.P.V., P.A.F., T.C.M., R.R.M., C.J.D.), Medical University of South Carolina; and the Department of Veterans Affairs Medical Center (Y.E., A.C.L., M.M., H.M., M.O.), Charleston, SC.
Correspondence to Christopher J. Drake, Department of Cell Biology and Anatomy, Medical University of South Carolina, 173 Ashley Ave, BSB 626, Charleston, SC 29425. E-mail drakec{at}musc.edu
Recent studies evaluating hematopoietic stem cell (HSC) potential raise the possibility that, in addition to embryonic sources, adult valve fibroblasts may be derived from HSCs. To test this hypothesis, we used methods that allow the potential of a single HSC to be evaluated in vivo. This was achieved by isolation and clonal expansion of single lineage-negative (Lin–), c-kit+, Sca-1+, CD34– cells from the bone marrow of mice that ubiquitously express enhanced green fluorescent protein (EGFP) combined with transplantation of individual clonal populations derived from these candidate HSCs into a lethally irradiated congenic non-EGFP mouse. Histological analyses of valve tissue from clonally engrafted recipient mice revealed the presence of numerous EGFP+ cells within host valves. A subpopulation of these cells exhibited synthetic properties characteristic of fibroblasts, as evidenced by their expression of mRNA for procollagen 1
1. Further, we show by Y-chromosome–specific fluorescence in situ hybridization analysis of female-to-male transplanted mice that the EGFP+ valve cells are the result of HSC-derived cell differentiation and not the fusion of EGFP+ donor cells with host somatic cells. Together, these findings demonstrate HSC contribution to the adult valve fibroblast population.
Key Words: adult stem cells • bone marrow • collagen • stem cell plasticity
This article has been cited by other articles:
 |
|
 |
|
  M. Pho, W. Lee, D. R. Watt, C. Laschinger, C. A. Simmons, and C. A. McCulloch Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1767 - H1778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Mayer Tissue Engineering for Cardiac Valve Surgery Card. Surg. Adult, January 1, 2008; 3(2008): 1649 - 1656. [Full Text]
|
|
|
|
 |
|
 A. C. Liu, V. R. Joag, and A. I. Gotlieb The Emerging Role of Valve Interstitial Cell Phenotypes in Regulating Heart Valve Pathobiology Am. J. Pathol., November 1, 2007; 171(5): 1407 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ogawa, A. C. LaRue, and C. J. Drake Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications Blood, November 1, 2006; 108(9): 2893 - 2896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Paruchuri, J.-H. Yang, E. Aikawa, J. M. Melero-Martin, Z. A. Khan, S. Loukogeorgakis, F. J. Schoen, and J. Bischoff Human Pulmonary Valve Progenitor Cells Exhibit Endothelial/Mesenchymal Plasticity in Response to Vascular Endothelial Growth Factor-A and Transforming Growth Factor-{beta}2 Circ. Res., October 13, 2006; 99(8): 861 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Skowasch, G. Nickenig, and G. Bauriedel Progenitor Cells and Valve Degeneration Circ. Res., May 26, 2006; 98(10): e71 - e71. [Full Text] [PDF]
|
|